Ani Pharmaceuticals earnings were -$20.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ANIP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$10.7M, down 56.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ANIP reported annual earnings of -$20.1M, with -217.4% growth. The next ANIP earnings date is May 8, 2025.
Ani Pharmaceuticals Earnings Reports & History FAQ
What were Ani Pharmaceuticals's earnings last quarter?
On ANIP's earnings call on Invalid Date, Ani Pharmaceuticals (NASDAQ: ANIP) reported Q4 2024 earnings per share (EPS) of -$0.55, up 2,850% year over year. Total ANIP earnings for the quarter were -$10.68 million. In the same quarter last year, Ani Pharmaceuticals's earnings per share (EPS) was $0.02.
The next ANIP earnings call is Invalid Date. Add ANIP to your watchlist to be reminded of Ani Pharmaceuticals's next earnings date.
What was ANIP's earnings growth in the past year?
As of Ani Pharmaceuticals's earnings date in Invalid Date, Ani Pharmaceuticals's earnings has grown year over year. ANIP earnings in the past year totalled -$20.15 million.
Is Ani Pharmaceuticals profitable or losing money?
As of the last Ani Pharmaceuticals earnings report, Ani Pharmaceuticals is currently losing money. Ani Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$18.52 million, a 198.63% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.